Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(15 sites)
United States
Mayo Clinic - Phoenix, Phoenix, Arizona USC Norris Comprehensive Cancer Center, Los Angeles, California Sarah Cannon Cancer Institute at HealthONE, Denver, Colorado Yale Cancer Center- New Haven, New Haven, Connecticut Mayo Clinic - Jacksonville, Jacksonville, Florida Florida Cancer Specialists - Sarasota, Sarasota, Florida University of Iowa, Iowa City, Iowa Mayo Clinic - Rochester, Rochester, Minnesota Cleveland Clinic, Cleveland, Ohio NEXT Austin, Austin, Texas Mary Crowley Cancer Research Centers, Dallas, Texas UT MD Anderson Cancer Center - Houston, Houston, Texas NEXT Huston, Houston, Texas NEXT Oncology, San Antonio, Texas NEXT Virginia, Fairfax, Virginia